BioCryst Pharmaceuticals | Resultado Líquido



Net Income Alterar Data
Alnylam Pharmaceuticals USD -57479000 26.28M 2025-03
Chugai Pharma JPY 97.23B 5.68B 2025-03
Daiichi Sankyo JPY 87.15B 25.22B 2025-03
DBV Technologies USD -27079000 4.06M 2025-03
Gilead Sciences USD 1.78B 529M 2024-12
GlaxoSmithKline GBP 1.62B 1.21B 2025-03
Glaxosmithkline GBP 414M 472M 2024-12
Incyte USD 158.2M 43.01M 2025-03
Ionis Pharmaceuticals USD -146938000 42.59M 2025-03
Neurocrine Biosciences USD 103.1M 26.7M 2024-12
PTC Therapeutics USD -65886000 40.77M 2024-12
Regeneron Pharmaceuticals USD 808.7M 109M 2025-03
Roche Holding CHF 1.01B 2.12B 2024-12
Sarepta Therapeutics USD -447508000 606.56M 2025-03
Ultragenyx Pharmaceutical USD -151080000 17.7M 2025-03
Vertex Pharmaceuticals USD 913M 132.4M 2024-12



BioCryst Pharmaceuticals Resultado Líquido - Valores atuais, dados históricos, previsões, estatísticas, gráficos e calendário econômico - Jul 2025.